Oracle (NYSE:ORCL) Trading Down 3.9% on Analyst Downgrade

Key Points

• Oracle shares fell 3.9% to about $144.48 after Freedom Broker cut its price target from $210 to $205, although it maintained a Buy rating. Trading volume was 43% above the daily average.
• Analysts remain broadly positive, with the stock carrying a “Moderate Buy” consensus rating and an average price target of $253.95, despite varied individual targets and ratings.
• Oracle’s latest results exceeded expectations, with revenue rising 29.6% year over year to $19.34 billion and EPS reaching $1.92. However, investors remain concerned about the company’s roughly $90 billion AI investment plan, potential free-cash-flow pressure and rising leverage.

Oracle Corporation (NYSE:ORCL - Get Free Report)'s stock price fell 3.9% during mid-day trading on Monday after Freedom Broker lowered their price target on the stock from $210.00 to $205.00. Freedom Broker currently has a buy rating on the stock. Oracle traded as low as $141.01 and last traded at $144.4840. 41,846,897 shares were traded during mid-day trading, an increase of 43% from the average daily volume of 29,296,166 shares. The stock had previously closed at $150.28.

Other analysts have also issued research reports about the company. Jefferies Financial Group lowered their target price on Oracle from $320.00 to $290.00 and set a "buy" rating on the stock in a report on Wednesday, September 2nd. CLSA began coverage on shares of Oracle in a research note on Monday, July 20th. They set a "hold" rating and a $145.00 price objective on the stock. DA Davidson restated a "buy" rating and set a $225.00 target price on shares of Oracle in a research report on Friday. Evercore reaffirmed an "outperform" rating and set a $245.00 price target on shares of Oracle in a research note on Monday, June 8th. Finally, Moffett Nathanson set a $325.00 price objective on Oracle in a research note on Thursday, June 11th. Two investment analysts have rated the stock with a Strong Buy rating, thirty have issued a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $253.95.

Insider Transactions at Oracle

In other Oracle news, Vice Chairman Jeffrey Henley sold 400,000 shares of Oracle stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $159.16, for a total transaction of $63,664,000.00. Following the sale, the insider directly owned 400,000 shares in the company, valued at $63,664,000. The trade was a 50.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 40.90% of the stock is owned by corporate insiders.

Key Stories Impacting Oracle

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle’s fiscal first-quarter results exceeded expectations, with revenue of $19.35 billion, up 29.6% year over year, and EPS of $1.92 versus the $1.74 consensus estimate. Management also issued fiscal 2027 guidance, supporting the long-term growth case. After Beating Expectations in Q1, Is Oracle Stock Due to Rally Higher?
• Positive Sentiment: Oracle reported strong demand for its cloud infrastructure: more than 300,000 GPUs were added during the quarter, while fleet utilization remained near 98%. The data point reinforces the potential for Oracle Cloud Infrastructure to benefit from sustained AI demand. Oracle's AI Chips Ran 97.9% Utilized Last Quarter
• Positive Sentiment: Analysts remain divided but several maintain bullish views. Barclays raised its price target to $252, while Argus reaffirmed a Buy rating with a $225 target. Larry Ellison’s cancellation of a planned sale of up to $7.5 billion of Oracle shares also removed a potential source of selling pressure. Barclays resets Oracle stock price target
• Neutral Sentiment: Oracle Health launched a clinical AI agent for U.S. inpatient nurses, expanding the company’s healthcare AI offerings and potentially supporting future product adoption. Oracle Health Clinical AI Agent Helps Nurses
• Negative Sentiment: Investors are increasingly worried that Oracle’s roughly $90 billion AI-related capital-spending plan will pressure free cash flow and increase leverage. The company has reportedly begun another round of layoffs while investing heavily in data centers, raising concerns about restructuring costs and the economics of its AI expansion. Oracle begins a new round of layoffs
• Negative Sentiment: The Ellison transaction created uncertainty because the sale plan was filed and canceled within roughly one day. Some investors interpreted the reversal as unusual, while broader technology-sector weakness, interest-rate concerns and discussion of greater AI oversight added to selling pressure. Why Oracle Stock Fell Quickly Today

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Bullseye Investment Management LLC bought a new stake in shares of Oracle in the 2nd quarter worth approximately $1,676,000. Bouchey Financial Group Ltd. bought a new position in Oracle in the 2nd quarter valued at about $229,000. Capstone Financial Advisors Inc. boosted its holdings in shares of Oracle by 3.6% in the second quarter. Capstone Financial Advisors Inc. now owns 1,809 shares of the enterprise software provider's stock valued at $265,000 after acquiring an additional 63 shares in the last quarter. Van Hulzen Asset Management LLC lifted its holdings in shares of Oracle by 0.7% in the second quarter. Van Hulzen Asset Management LLC now owns 11,815 shares of the enterprise software provider's stock valued at $1,731,000 after buying an additional 81 shares during the period. Finally, MCF Advisors LLC boosted its position in shares of Oracle by 3.4% during the 2nd quarter. MCF Advisors LLC now owns 20,411 shares of the enterprise software provider's stock valued at $2,991,000 after purchasing an additional 677 shares in the last quarter. 42.44% of the stock is currently owned by institutional investors.

Oracle Stock Down 3.9%

The company has a debt-to-equity ratio of 1.75, a current ratio of 1.17 and a quick ratio of 1.12. The stock has a market capitalization of $416.18 billion, a P/E ratio of 22.65, a PEG ratio of 1.10 and a beta of 1.74. The stock's fifty day moving average is $141.08 and its two-hundred day moving average is $160.52.

Oracle (NYSE:ORCL - Get Free Report) last announced its earnings results on Thursday, September 10th. The enterprise software provider reported $1.92 EPS for the quarter, topping the consensus estimate of $1.74 by $0.18. The company had revenue of $19.34 billion during the quarter, compared to analysts' expectations of $19.13 billion. Oracle had a net margin of 26.36% and a return on equity of 47.43%. The business's revenue for the quarter was up 29.6% on a year-over-year basis. During the same period last year, the company posted $1.47 earnings per share. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. As a group, research analysts predict that Oracle Corporation will post 6.6 earnings per share for the current fiscal year.

Oracle Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 23rd. Shareholders of record on Friday, October 9th will be paid a $0.50 dividend. The ex-dividend date is Friday, October 9th. This represents a $2.00 dividend on an annualized basis and a yield of 1.4%. Oracle's payout ratio is 31.35%.

About Oracle

Oracle Corporation is a global enterprise technology company that develops and provides database software, cloud infrastructure, business applications and related technology services. Its offerings help organizations manage data, run applications, support business operations and build technology environments across on-premises, hybrid and cloud-based settings.

The company's products include Oracle Database, MySQL, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud applications for enterprise resource planning, financial management, human resources, supply chain management, customer experience and industry-specific operations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.